ROCK2 and cholangiocarcinoma: These findings support the notion that ROCK2 primarily mediates pemetrexed resistance through ferroptosis and is not involved in other forms of cell death, highlighting a novel regulatory pathway that could be targeted for therapeutic strategies in CCA treatment.